Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma-Reference-Cited by-同舟云学术

Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma

Published:2014-03 Issue:3 Volume:24 Page:488-493
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Hsieh Ching-Jung¹,Wang Pei-Wen¹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2012.0611

Reference22 articles.

1. Thyroid autoantibodies in thyroid cancer: Incidence and relationship with tumour outcome

2. Significance of Antithyroglobulin Autoantibodies in Differentiated Thyroid Carcinoma

3. Anticuerpos anti-tiroglobulina en el seguimiento de pacientes con cáncer diferenciado de tiroides: ¿Marcadores de enfermedad residual o recidivante?

4. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy

5. Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer;Frontiers in Endocrinology;2024-04-24

2. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer;Endocrine Practice;2024-02

3. Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside;Reviews in Endocrine and Metabolic Disorders;2023-10-27

4. Predicting clinical outcomes of patients with serum thyroglobulin antibodies after thyroidectomy for differentiated thyroid cancer: a retrospective study from a UK regional center;Minerva Endocrinology;2023-07

5. Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer;Annales d'Endocrinologie;2023-04